We warmly invite the submission of abstracts that present original scientific research, clinical findings, or evidence-based best practice models across all areas of Infectious Diseases, Virology, Microbiology, and Antimicrobial Resistance.
Contributions may include experimental studies, clinical case analyses, public health investigations, laboratory advancements, policy perspectives, or innovative intervention strategies.
The topics and tracks listed below are intended as a general guide to the scope of the conference and are not exhaustive.
1
Infectious Diseases and Global Health
2
Viral Infections
3
Bacterial Infections
4
Fungal Infections
5
Vector-borne Diseases
6
Virology and HIVAIDS
7
Immunology and Clinical Microbiology
8
Antiviral Drug Resistance
9
Catheter-Associated Urinary Tract Infection
10
Emerging Infectious Diseases
11
Hospital-Acquired Infections HAIs
12
Maternal-Fetal Infections
13
Next-Generation Antibiotics
14
Pediatric Infectious Diseases
15
Sepsis Diagnosis and Care
16
Zoonotic Diseases
17
Neurological and CNS Infections
18
Healthcare-Associated Infections
19
Ophthalmological Infectious Diseases
20
Lower Respiratory and Pediatric IDs
21
Genomics and Infectious disease
22
Special Session on COVID-19
23
Vaccines and Immunizations
24
Antibiotic Sensitivity Testing
25
Blood-Borne Disease
26
Contagious Disease
27
Encephalitis
28
Global Pandemic Preparedness
29
Influenza Surveillance Systems
30
Microbiome and Immunity
31
Occupational Safety and Health OSH
32
Point-of-Care Testing POCT
33
Travel-Related Infections
34
Tropical Diseases and Parasitic Diseases
35
Sexually Transmitted Diseases and STIs
36
Pathophysiology and Diagnosis
37
Clinical Trials and Case Studies
38
Influencing Factors of IDs
39
Advanced Treatments and Technologies
40
Oral and Maxillofacial Infections
41
Prevention and Control
42
Public Health and Epidemiology
43
Artificial Intelligence in ID
44
Climate Change and Infections
45
Gastroenteritis
46
HIV and Co-Infections
47
Malaria Elimination Strategies
48
Neglected Tropical Diseases NTDs
49
One Health Approach
50
Rapid Diagnostic Innovations
51
Tuberculosis Drug Resistance